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Background: With 75% of the Ethiopian population at risk of malaria, accurate diagnosis is crucial for malaria
treatment in endemic areas where Plasmodium falciparum and Plasmodium vivax co-exist. The present study evaluated
the performance of regular microscopy in accurate identification of Plasmodium spp. in febrile patients visiting health
facilities in southern Ethiopia.
Methods: A cross-sectional study design was employed to recruit study subjects who were microscopically positive for
malaria parasites and attending health facilities in southern Ethiopia between August and December 2011. Of the 1,416
febrile patients attending primary health facilities, 314 febrile patients, whose slides were positive for P. falciparum,
P. vivax or mixed infections using microscopy, were re-evaluated for their infection status by PCR. Finger-prick blood
samples were used for parasite genomic DNA extraction. Phylogenetic analyses were performed to reconstruct the
distribution of different Plasmodium spp. across the three geographical areas.
Results: Of the 314 patients with a positive thick blood smear, seven patients (2%) were negative for any of the
Plasmodium spp. by nested PCR. Among 180 microscopically diagnosed P. falciparum cases, 111 (61.7%) were
confirmed by PCR, 44 (24.4%) were confirmed as P. vivax, 18 (10%) had mixed infections with P. falciparum and P. vivax
and two (1.1%) were mixed infections with P. falciparum and P. malariae and five (2.8%) were negative for any of the
Plasmodium spp. Of 131 microscopically diagnosed P. vivax cases, 110 (84%) were confirmed as P. vivax, 14 (10.7%) were
confirmed as P. falciparum, two (1.5%) were P. malariae, three (2.3%) with mixed infections with P. falciparum and
P. vivax and two (1.5%) were negative for any of the Plasmodium spp. Plasmodium falciparum and P. vivax mixed
infections were observed. Plasmodium malariae was detected as mono and mixed infections in four individuals.
Conclusion: False positivity, under-reporting of mixed infections and a significant number of species mismatch needs
attention and should be improved for appropriate diagnosis. The detection of substantial number of false positive
results by molecular methodologies may provide the accurate incidence of circulating Plasmodium species in the
geographical region and has important repercussions in understanding malaria epidemiology and subsequent control.
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Malaria is one of the major causes of mortality and mor-
bidity in tropical and subtropical countries with an esti-
mated 655,000 malaria deaths in 2010, and 91% of these
cases were in sub-Saharan Africa [1]. Malaria is caused
by parasites of the genus Plasmodium, with four different
species specifically infecting humans (Plasmodium fal-
ciparum, Plasmodium vivax, Plasmodium ovale and
Plasmodium malariae) and parasites of non-human pri-
mates, such as Plasmodium knowlesi, infecting humans
occasionally. Plasmodium falciparum is the most viru-
lent species contributing to a larger extent to malarial
deaths in Africa, including Ethiopia. Plasmodium vivax
and P. ovale form resting stages in the liver as hypno-
zoites and can cause a clinical relapse [2].
Ethiopia’s diverse topography and climatic conditions
make malaria a seasonal infection covering 75% of the
prefecture of the country [3] and malaria epidemic occur
mostly in high and low land arid regions of the country
[4]. The majority of Ethiopian regional states (Oromia,
Amhara, Tigray, South Nation, and Nationalities, and
People’s Region (SNNPR)) have experienced the 1998 mal-
arial epidemic [5]. Plasmodium falciparum accounts for
60-70% and P. vivax accounts for 30-40% of malaria cases
in Ethiopia, although these proportions might fluctuate on
the spatial and temporal scale [6]. Anopheles arabiensis
is the main vector widely distributed in Ethiopia, while
Anopheles pharoensis, Anopheles funestus and Anopheles
nili contribute as secondary vectors [7].
Hospitals and health centres in Ethiopia diagnose mal-
aria by microscopy, whereas the health posts employ rapid
diagnostic tests (RDT) for diagnosis of P. falciparum and
P. vivax [3]. The use of RDTs in malarial diagnosis does
not require skilled personnel compared to microscopy and
reduces inappropriate use of anti-malarial drugs [4]. How-
ever, RDTs do not allow quantification and differentiation
of different Plasmodium species other than P. falciparum
and P. vivax. Microscopy remains the golden standard of
choice to determine the disease burden. Additionally mi-
croscopy can identify febrile patients negative for any
Plasmodium infection, thereby directing patients towards
an alternative treatment algorithm [5,8].
Microscopy is a valuable technique and has been shown
to detect about 75% of malaria infections in high transmis-
sion areas and miss up to 88% of infections in low transmis-
sion areas [9]. The detection of low numbers of parasites,
and the labour-intensive procedure remain a hurdle in dif-
ferentiating Plasmodium species by microscopy [10]. In
endemic regions, P. malariae and P. ovale infections are
frequently overlooked. Dedicated laboratory personnel
with good experience remain the key for accurate diagnosis
of P. malariae and P. ovale in areas where P. falciparum
and P. vivax predominate. Prompt and accurate diagnosis
followed by an effective treatment largely depends on theskills of the laboratory personnel, who can spend appropri-
ate time in examining blood film. On the other hand, mi-
croscopy techniques fail to detect mixed infections, when
one of the Plasmodium species is present at low levels.
In recent years, molecular detection of Plasmodium with
higher sensitivity is gaining importance for accurate detec-
tion. Methods such as nested PCR are capable of detecting
few parasites/μl in blood [10-15]. The nested PCR ap-
proach identifies the species-specific Plasmodium DNA by
amplifying the 18s ribosomal RNA region of the parasite
[11]. The ribosomal RNA genes in Plasmodium are four
to eight copies per haploid genome and are scattered on
different chromosomes, with two distinct subgroups whose
expression is regulated both by type A and type B genes
that are expressed in the asexual and sexual stages in the
vertebrate host, respectively [16,17]. The nucleotide se-
quence of the SSUrRNA is largely conserved between Plas-
modium and different species reveal genetic heterogeneity
in their respective ribosomal regions. This variation, to-
gether with the abundance of ribosomes in the parasite,
has led to the development of effective diagnostic probes
based on SSUrRNA sequences [18].
In Ethiopia, previous reports on malaria surveillance
were based on microscopic results. The majority of these
studies were conducted either with little or no information
or with few technical resources [19-21]. In the current
study, the accuracy of results obtained by routine micros-
copy performed by experienced laboratory personnel was
compared to molecular detection methodologies. These
microscopists were experienced and were supervised by
fellow senior laboratory technologists. In addition, they
received additional training on a regular basis to improve
their detection skills on differentiating Plasmodium spp.
Additionally, 18SrRNA genes were subsequently sequenced
and phylogenetic relationship was investigated to determine
the genetic diversity of the Plasmodium spp.
Methods
Study area and design
A health institution-based study targeting febrile pa-
tients attending primary health facilities was conducted
in southern Ethiopia between August and December, 2011.
Malaria transmission in Ethiopia is seasonal with higher
transmission peaks in the months between September and
December, and between April and May following rainy sea-
sons. The three study sites included in this study were
Omo Nada, Bala Wajo and Arba Minch.
Study participants
Study participants were recruited from the routine health
delivery system. Self-presenting febrile patients attending
health centres in Omo Nada (n = 713), Bala Wajo (n = 312)
and Arba Minch (n = 391) and whose age was at least six
months between August and December 2011 were eligible
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fected either with P. falciparum or P. vivax or with a mixed
infection using the existing health care delivery system
within the target health centres was approached for con-
sent immediately after receiving their laboratory result. For
those who consented to be part of the study, approximately
5–10 μl finger-prick blood sample was collected. No add-
itional clinical assessment was carried out at the time of
recruitment.
Sampling
In total, 314 finger-prick blood samples were collected
for molecular diagnosis from microscopy-positive outpa-
tients in Omo Nada (n = 132), Bala Wajo (n = 99) and Arba
Minch (n = 83) from all patients attending the health facil-
ities during the study period. Blood samples were col-
lected in Whatman 3 mm filter papers. These patients
were positive in the routine health delivery system using
microscopy either for P. falciparum or P. vivax. On collec-
tion, the blood spots were air-dried and stored in a separ-
ate, clean, sealed, plastic pouch at room temperature for
further analysis.
Ethics
Ethical clearances were obtained from the institutional
review boards of Aklilu Lemma Institute of Pathobiology,
Jimma University and Armauer Hansen Research Institute.
Informed written consent and assent (in the case of chil-
dren between 12 and 18 years of age) were obtained from
each patient or a parent/legal guardian. The study participa-
tion was voluntary and had no influence on the treatment
provision at the respective health facilities. All patient infor-
mation were kept confidential.
Blood film management and patient care
Giemsa-stained thick and thin blood films are routinely
used in Ethiopian hospitals and health centres for the
detection of Plasmodium without any quantitative esti-
mation of parasitaemia. In the current study, thin and
thick blood films were prepared from finger-prick blood
and air-dried, fixed in methanol and subsequently stained
for 20–30 minutes in Giemsa. At least 100 thick field films
with an oil immersion lens at 100X magnification were
examined before a slide was considered negative. All in-
dividuals positive for P. falciparum were treated with
artemether-lumefantrine (AL), P. vivax-positive patients
were treated with chloroquine and mixed infections were
treated with AL.
DNA extraction and molecular detection
Genomic DNA was isolated using QIAgen DNA Mini
Kit blood and tissue (QIAGEN, Germany) according to
the manufacturer’s instructions. The extracted DNA was
stored at −20°C until use. Nested PCR assay were carriedout as previously described elsewhere [20]. DNA sam-
ples were amplified by species-specific primer pairs de-
signed to amplify small subunit ribosomal ribonucleic
acid (ssrRNA) genes of P. falciparum, P. vivax, P. malariae
and P. ovale (Table 1). In brief, both the primary and
nested amplifications were carried out in a 20 μl reaction
volume containing 1X buffer, 2.5 mM MgCl2, 200 μM
dNTPs, 200 nM primers, and 1U Taq DNA-polymerase
with approximately 10 ng of DNA template on a PTC-200
Thermal cycler (MJ Research, USA). The Plasmodium
genus-specific amplification was followed by P. falciparum,
P. vivax, P. malariae and P. ovale species-specific PCR
amplification. Thermal cycling parameters for first round of
amplification were: initial denaturation at 94°C for 5 min,
followed by 40 cycles of, respectively, 25 sec at 94°C for de-
naturation, 25 sec for 58°C for annealing temperature, and
60 sec at 72°C extension and the thermal parameters for
the second PCR were followed by 30 cycles of, respectively,
25 sec at 94°C for denaturation, 25 sec for 56°C for an-
nealing temperature, and 60 sec at 72°C extension. This
was followed by a final extension of 10 min at 72°C. In
each run negative and positive controls were included.
Genomic DNA from healthy as well as from individuals
who had not travelled to malaria-endemic areas were in-
cluded as negative controls in all PCR diagnostic assays.
Amplicons were separated on a 1.2% agarose gel electro-
phoresis run along with a 100 bp DNA ladder (Invitrogen,
Karlsruhe, Germany). The presence or absence of different
Plasmodium species was confirmed with representative
amplicon size that were species-specific. Samples that
failed to amplify were subjected to repeated amplification
procedures with different PCR additives.
Sequencing and phylogenetic analysis
Thirty-one (n = 31) Plasmodium-positive samples were
further selected to determine the genetic diversity of the
existing subspecies from three collected sites. The selected
Plasmodium samples included 11 P. falciparum (three
from Omo Nada; two from Bala Wajo; six from Arba
Minch), 16 P. vivax (nine from Omo Nada; four from Bala
Wajo; three from Arba Minch) and four P. malariae from
Omo Nada. PCR products were cleaned up using Exo-
SAP-IT (USB, Affymetrix, USA) and 1 μl of the purified
product were directly used as templates for sequencing,
using the BigDye terminator v. 2.0 cycle sequencing kit
(Applied Biosystems, USA) on a ABI 3130XL DNA se-
quencer, according to the manufacturer’s instructions.
Five 18srRNA-specific DNA sequences for each Plasmo-
dium (P. falciparum JQ627152.1, P. vivax HF945443.1,
HF945441.1 and JQ627152.1 and P. malariae KC906731.1)
obtained from NCBI database were aligned with 31 sam-
ples (11 P. falciparum samples, 16 P. vivax samples and
four P. malariae samples) sequenced for 18srRNA using
Codon code Aligner 4.0 software. The phylogenetic tree
Table 1 Species-specific primers used for nested PCR and sequencing
Malaria species Primer Primer sequence 5′-3′ Size (bp)
Plasmodium rPLU5 CCTGTTGTTGCCTTAAACTTC 1,100
rPLU6 TTAAAATTGTTGCAGTTAAAAC
P. falciparum rFAL1 250
rFAL2 ACACAATGAACTCAATCATGACTACCCGTC
P. vivax rVIV1 CGCTTCTAGCTTAATCCACATAACTGATAC 120
rVIV2 ACTTCCAAGCCGAAGCAAAGAAAGTCCTTA
P. malariae rMAL1 ATAACATAGTTGTACGTTAAGAATAACCGC 144
rMAL2 AAAATTCCCATGCATAAAAAATTATACAAA
P. ovale rOVA1 ATCTCTTTTGCTATTTTTTAGTATTGGAGA 800
rOVA2 GAAAAGGACACATTAATTGTATCCTAGTG
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on Kimura 2-parameter model using the MEGA ver5.2
software [22] with 1000 bootstrap iterations.
Results
Study subject characterization
Blood films were examined from a total of 314 study
participants aged at least six months for the presence of
malaria parasites, using microscopy as well as by species-
specific nested PCR method. Among the study participants,
21% were children less than four years of age, 60.2% were
males and 38.9% were females. Of these study participants,
307 were reconfirmed positive for the presence of Plasmo-
dium DNA by PCR. Of 314 study subjects, 21% were
children less than four years of age, 189(60.2%) were male
and 125(38.9%) were female. Among 307 PCR-confirmed
cases, 125(40.7%) were positive for P. falciparum, 154
(50.2%) were positive for P.vivax, two (0.7%) were positive
for P. malariae, 24(7.8%) were positive for P. falciparum
and P. vivax double infections, two (0.7%) were positive
for P. falciparum and P. malariae double infection. Seven
study participants remained negative for all species inves-
tigated (Table 2).
All single and mixed infections of P. malariae were
not detected by the golden standard microscopic examin-
ation. Most of the Plasmodium-infected individuals be-
long to the age group between five and 14 years (n = 154,Table 2 Malaria parasite species stratified by sex and age am
Pf (%) Pv (%) Pm (%
Sex Male 75 (39.7) 91 (48.1) 2 (1.1)
Female 50 (40) 63 (50.4) 0 (0)
Age group (years) ≤ 4 29 (43.9) 32 (48.5) 1 (1.5)
5-14 55 (35.7) 81 (52.6) 1 (0.6)
15-28 22 (37.3) 28 (47.5) 0 (0)
29-45 13 (46.4) 12 (42.9) 0 (0)
>46 6 (85.7) 1 (14.3) 0 (0)
Pf = P. falciparum, Pv = P. vivax , Pm = P. malariae, Po = P. ovale, Pf + Pv = P. falciparum49%). Of these 154 individuals aged from 5 to 14 years, 81
(52.6%) were infected by P. vivax and 55 (35.7%) infected
by P. falciparum. A total of 66 (21%) were children less
than four years. The ages of all P. malariae-positive cases
that were detected by PCR were below 28 years (Table 2).
Comparison of molecular diagnosis with microscopy
Comparison of results from microscopy and nested PCR
is summarized in Table 3. Microscopic examination of
blood films reported cases of P. falciparum (180 positive
cases), cases of P. vivax (131 positive cases) in all the
study sites. Three mixed infections of P. falciparum and
P. vivax were detected in the samples from Omo Nada.
In relative terms the highest numbers of P. falciparum
and P. vivax patients were reported from Omo Nada
site. Of all 180 microscopically confirmed P. falciparum
cases, 111 cases (62%) were mono-infections for P. fal-
ciparum, 44 cases (24%) were P. vivax mono-infections,
18 cases (10%) were double infections with P. falciparum
and P. vivax, two cases (1%) were double infections with
P. falciparum and P. malariae, and five cases (3%) were
confirmed negative for any Plasmodium species by the
nested PCR. Of all 131 microscopically confirmed P. vivax
cases, 110 cases (84%) were P. vivax mono-infections, 14
cases (11%) were mono-infections for P. falciparum, two
cases (2%) were detected for P. malariae mono-infection,
three cases (2%) were double infections with P. falciparumong 314 study participants in southern Ethiopia
) Pf + Pv (%) Pf + Pm (%) Negative (%) Total (%)
16 (8.5) 1 (0.5) 4 (2.1) 189 (60.2)
8 (6.4) 1 (0.8) 3 (2.4) 125 (38.9)
4 (6.1) 0 (0) 0 (0.0) 66 (21.0)
12 (7.8) 1 (0.6) 4 (2.6) 154 (49.0)
5 (8.5) 1 (1.7) 3 (5.1) 59 (17.8)
3 (10.7) 0 (0) 0 (0.0) 28 (8.9)
0 (0) 0 (0) 0 (0.0) 7 (2.2)
and P. vivax, Pf + Pm = P. falciparum and P. malariae.
Table 3 Comparison of microscopy and nested PCR in the diagnosis of malaria in southern Ethiopia
Microscopy Nested PCR
P. falciparum P. vivax P. malariae P. falciparum + P. vivax P. falciparum + P. malariae Negative Total
P. falciparum 111 44 0 18 2 5 180
P. vivax 14 110 2 3 0 2 131
P. falciparum + P. vivax 0 0 0 3 0 0 3
Total 125 154 2 24 2 7 314
Pf = P. falciparum, Pv = P. vivax, Pm = P. malariae, Po = P. ovale, Pf + Pv = P. falciparum and P. vivax, Pf + Pm = P. falciparum and P. malariae.
Table 5 Ethiopian Plasmodium species with their single
nucleotide polymorphism
Plasmodium no Insertion Deletion Substitution
N21 1 3 18
Pf A9 1 3 14
N23 1 3 14
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for any Plasmodium species by the nested PCR. Molecular
detection by nested PCR identified that many of the
P. vivax cases (44/180) were incorrectly diagnosed as
P. falciparum by microscopy. A total of seven negative
cases are observed. These seven negative cases were recon-
firmed for their status by amplification for Pfmdr1 and
Pfcrt alleles. P. ovale was not detected either by micros-
copy or by nested PCR. In total, 23 mixed infections were
detected by nested PCR compared to microscopy-based
detection.
Gametocyte identification using microscopy
Of all the 314 study subjects, 32 (10.2%) carried gameto-
cytes. Of which, 17(5.5%) were P. vivax and 15 (4.8%) were
P. falciparum gametocyte stage. All the gametocyte stages
were identified from 307 study subjects positive for Plas-
modium parasites.
Phylogenetic analysis
The result of 31 Ethiopian specific isolates (11 P. falcip-
arum isolates, 16 P. vivax isolates and four P. malariae
isolates) originated from different geographical areas and
sequenced for 18srRNA, is summarized in Table 4. The
identified nucelotide substitutions including the insertions
and deletions observed in different Plasmodium isolates is
summarized in Table 5. The reconstructed phylogenetic
tree inferred two distinct clades. All P. vivax isolates from
Ethiopia matched in one group whereas all the P. falcip-
arum and P. malariae clustered in another clade. Within
the main clade, P. vivax clustered into three, P. falciparum
clustered into two and P. malariae placed into one sub-
cluster (Figure 1). The first subcluster with nine isolates
contained 70 single nucleotide polymorphisms (SNP), theTable 4 Parasite isolates utilized for phylogenetic









P. falciparum 3 (N21-N23) 2 (B3-B4) 6 (A3-A6, A8-A9) 11
P. vivax 9 (N25-N33) 4 (B6-B9) 3 (A10-A11, A17) 16
P. malariae 4 (N41-N44) 0 0 4second subcluster included 150 SNPs and the third sub-
cluster contained 53 SNPs.Discussion
Early diagnosis and prompt treatment is crucial in con-
trolling malaria infections. Microscopic diagnosis and
RDTs are widely used methods for malaria surveillance
in Ethiopia. The most fatal species, P. falciparum, must be
rightly differentiated from the other Plasmodium species
(especially P. vivax), thereby directing febrile patients to-
wards prompt treatment that can save lives. The rationale
of the study was to assess species mismatch and the speci-
ficity of microscopy in differentiating Plasmodium spp. in
regions where two virulent species of Plasmodium, namely
P. falciparum and P. vivax, co-exist.
In Ethiopia, P. falciparum and P. vivax are the pre-
dominant parasite with a prevalence of 55 and 45%, re-
spectively [23]. In most endemic regions across Ethiopia
both Plasmodium co-exist. The present study report a
prevalence of P. vivax (55%) remained high compared to
P. falciparum (45%) during this season. The rationale of
the study was to evaluate the limitations of microscopy
in differentiating Plasmodium in Ethiopia that may con-
tribute to improve individual’s life by an appropriate ad-
ministration of anti-malarials. When slide positive casesB6 6 0 26
Pv sub cluster 1 B8 5 0 24
B7 5 0 23
N32 0 7 4
Pv sub cluster 2 N29 0 7 4
A11 0 7 4
Pv sub cluster 3 B9 2 0 1
Pf = P. falciparum, Pv = P. vivax, Pm = P. malariae, Po = P. ovale, Pf + Pv = P.
falciparum and P. vivax, Pf + Pm = P. falciparum and P. malariae.
Figure 1 Reconstructed phylogenetic tree using 18S ribosomal RNA nucleotide sequence from Plasmodium field isolates.
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high proportion of P. vivax individuals were misdiag-
nosed as P. falciparum-positive and were treated with
AL, a drug of choice in treating P. falciparum infections.
However the treatment of 14 cases (11%) microscopically
diagnosed as P. vivax were mono-infections for P. falcip-
arum. These results imply that these individuals were mis-
treated with chloroquine rather with AL. This may have
had a considerable impact on treatment failure as they were
misdiagnosed microscopically. Such a scenario may lead to
severe malaria-related ailments and to the extent of mortal-
ity in these 14 cases. All the laboratories in the study area
did not use buffer when preparing Giemsa staining solu-
tion. This might be one of the reasons for a high report of
species mismatch and low sensitivity of microscopy. pH is
an important component of Giemsa stain and pH 7.2 is rec-
ommended, as it highlights the Schüffner's dots of P. vivax
and Maurer's clefts of P. falciparum, which are essential
characteristics for malaria diagnosis by microscopy.
Additionally, microscopy methodologies failed to detect
multiple infections. As demonstrated by a plethora of
other studies that compared microscopy with moleculardiagnosis [12,24-30], nucleic acid testing by the nested
PCR approach provides an accurate differentiation of Plas-
modium, and that helps to rule out false positives and
mixed infections [10,31]. A high prevalence of mixed in-
fections, especially with P. falciparum and P. vivax, irre-
spective of study sites were observed. Of the 21 individuals
with double infections, three were reported as P. vivax and
18 were P. falciparum-positive by microscopy. The reason
why microscopy failed to detect mixed infections could be
due to the presence of higher numbers of parasites of one
species relative to the other. Moreover, in laboratories with
overwhelming numbers of patients, the workload is not
proportional to the laboratory staff involved. Therefore,
this leads the laboratory personnel not to utilize adequate
time to examine the blood film.
Although P. ovale is one of the prevalent parasites in
western Africa [32], no individuals infected with P. ovale
were observed in any of the studied three sites. Add-
itionally, P. malariae, a species which is less common
in Ethiopia, was detected in four individuals with two
as mono-infection and two as double infection with P.
falciparum. A total of seven (2%) negative cases were
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P. falciparum and two for P. vivax. The false positive
cases were reconfirmed as negative for other Plasmodium
spp. additionally; these false positive samples were sub-
jected to subsequent amplification for both pfmdr1 and
pfcrt alleles. Microscopy failed to detect P. malariae
mono-infections and mixed infections. The dominance of
either P. falciparum or P. vivax can possibly be a reason
for the failure to detect P. malariae by microscopy. In
addition, the pattern of fever and duration of the
erythrocyte 72-hour developmental cycle may contrib-
ute to P. malariae low numbers. Although microscopy
remains as a gold standard, it has its limitations to dif-
ferentiate Plasmodium spp., in addition to low parasite
counts [33]. Factors influencing the precision of blood-
smear diagnosis including the experience and motiv-
ation of technicians, smear quality, the inability to
determine parasite species at low parasitemia, the loss
of slide quality with time and the quality of the reagents.
Artifacts resembling malaria are common. Currently
RDTs are widely used in malaria surveillance pro-
grammes to differentiate only P. falciparum or P. vivax
infections [34].
Many studies within Ethiopia reported conflicting re-
sults on the presence of P. malariae prevalence, includ-
ing Federal Ministry of Health of Ethiopia. A few of these
reported the presence only of P. falciparum and P. vivax
[6], whereas other reports demonstrated the prevalence of
P. malariae in addition to the two dominant species in the
country [35]. A study from Thailand reported that fever
induced by low parasitaemia by P. vivax might limit para-
sitaemia and the pathogenic potential of P. falciparum
[35]. In addition, the role of P. malariae in the aetiology of
human glomerulonephritis is based on circumstantial clin-
ical and epidemiological evidence and on renal biopsies
showing granular immune deposits in the glomeruli [36].
Microscopic diagnosis of malaria is the most widely used
approach for epidemiological studies. The blood smear
provides much vital information that helps to correlate
the parasite density to clinical malaria. Unfortunately,
microscopy detection has both qualitative and quantita-
tive limitations. Blood-smear microscopy reaches its limit
of detection when parasitaemia falls below 40 infected red
blood cells (IRBC) per μl of blood (108 total body parasites),
and the reproducibility of parasite counts and species iden-
tification is frequently inconsistent [37]. Factors influencing
the precision of microscopy-based diagnosis largely depend
on high experience, motivation of technicians, due diligence
in examination over an adequate period of time, smear and
slide quality, and differentiation from artifacts resembling
malaria [38]. False positives are common in laboratories
with high patient flow and when the numbers of laboratory
personnel are not proportional to the laboratory workload.
Difficulties are compounded when infections contain morethan one parasite species. The other disadvantage of a false
positive microscopic result is patients being exposed to
drugs leading to unnecessary side effects and drug wastage.
Patients will also be delayed from early treatment for other
infections and that can be life threatening [39].
The phylogenetic relatedness of P. vivax and P. falcip-
arum isolates is rather not restricted to one region, but
seems to be widespread across different geographical
regions within Ethiopia as the isolates from Abra Minch
are also found in homology to isolates from Omo Nada.
All isolates of P. malariae were represented from the
site Omo Nada and were clustered together. Moreover,
P. vivax showed a more diverse population than P. fal-
ciparum and P. malariae.Conclusions
False positivity, under-reporting of mixed infections and
a significant number of species mismatch needs attention
and should be improved for accurate diagnosis. Efforts
must continue to re-train laboratory staff and provision of
appropriate reagents based on the standard staining pro-
cedure for the diagnosis of Plasmodium parasite shall im-
prove diagnosis. Overall, the finding of the current study
highlights an important concern in the diagnosis of malaria
by microscopy alone in southern Ethiopia and has import-
ant repercussions in understanding malaria epidemiology
and subsequent control.Competing interests
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